世界の遺伝性血管性浮腫薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Hereditary Angioedema Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z06895
• 出版社/出版日：GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、102ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、遺伝性血管性浮腫薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝性血管性浮腫薬の種類別市場規模（C1エステラーゼ阻害剤、カリクレイン阻害剤、選択的ブラジキニンB2受容体拮抗薬）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・遺伝性血管性浮腫薬の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Pharming Group NV、Takeda、CSL Limited、IBio Inc.、BioCryst Pharmaceuticals, Inc.、Ionis Pharmaceuticals, Inc.
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：C1エステラーゼ阻害剤、カリクレイン阻害剤、選択的ブラジキニンB2受容体拮抗薬
・用途別分析2016年-2026年：小売薬局、病院薬局、オンライン薬局
・遺伝性血管性浮腫薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・遺伝性血管性浮腫薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・遺伝性血管性浮腫薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・遺伝性血管性浮腫薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・遺伝性血管性浮腫薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Hereditary Angioedema Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hereditary Angioedema Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Hereditary Angioedema Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Hereditary Angioedema Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist

Market segment by Application can be divided into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

The key market players for global Hereditary Angioedema Drug market are listed below:
Pharming Group NV
Takeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Hereditary Angioedema Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hereditary Angioedema Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Market Analysis by Application
1.3.1 Overview: Global Hereditary Angioedema Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Hereditary Angioedema Drug Market Size & Forecast
1.4.1 Global Hereditary Angioedema Drug Sales in Value (2016-2026))
1.4.2 Global Hereditary Angioedema Drug Sales in Volume (2016-2026)
1.4.3 Global Hereditary Angioedema Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Hereditary Angioedema Drug Production Capacity Analysis
1.5.1 Global Hereditary Angioedema Drug Total Production Capacity (2016-2026)
1.5.2 Global Hereditary Angioedema Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hereditary Angioedema Drug Market Drivers
1.6.2 Hereditary Angioedema Drug Market Restraints
1.6.3 Hereditary Angioedema Drug Trends Analysis
2 Manufacturers Profiles
2.1 Pharming Group NV
2.1.1 Pharming Group NV Details
2.1.2 Pharming Group NV Major Business
2.1.3 Pharming Group NV Hereditary Angioedema Drug Product and Services
2.1.4 Pharming Group NV Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Hereditary Angioedema Drug Product and Services
2.2.4 Takeda Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 CSL Limited
2.3.1 CSL Limited Details
2.3.2 CSL Limited Major Business
2.3.3 CSL Limited Hereditary Angioedema Drug Product and Services
2.3.4 CSL Limited Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 IBio Inc.
2.4.1 IBio Inc. Details
2.4.2 IBio Inc. Major Business
2.4.3 IBio Inc. Hereditary Angioedema Drug Product and Services
2.4.4 IBio Inc. Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 BioCryst Pharmaceuticals, Inc.
2.5.1 BioCryst Pharmaceuticals, Inc. Details
2.5.2 BioCryst Pharmaceuticals, Inc. Major Business
2.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product and Services
2.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Ionis Pharmaceuticals, Inc.
2.6.1 Ionis Pharmaceuticals, Inc. Details
2.6.2 Ionis Pharmaceuticals, Inc. Major Business
2.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product and Services
2.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Hereditary Angioedema Drug Sales by Manufacturer
3.1 Global Hereditary Angioedema Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Hereditary Angioedema Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Hereditary Angioedema Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Hereditary Angioedema Drug Manufacturer Market Share
3.4.2 Top 6 Hereditary Angioedema Drug Manufacturer Market Share
3.5 Global Hereditary Angioedema Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Hereditary Angioedema Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hereditary Angioedema Drug Market Size by Region
4.1.1 Global Hereditary Angioedema Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Hereditary Angioedema Drug Revenue by Region (2016-2026)
4.2 North America Hereditary Angioedema Drug Revenue (2016-2026)
4.3 Europe Hereditary Angioedema Drug Revenue (2016-2026)
4.4 Asia-Pacific Hereditary Angioedema Drug Revenue (2016-2026)
4.5 South America Hereditary Angioedema Drug Revenue (2016-2026)
4.6 Middle East and Africa Hereditary Angioedema Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Hereditary Angioedema Drug Sales in Volume by Type (2016-2026)
5.2 Global Hereditary Angioedema Drug Revenue by Type (2016-2026)
5.3 Global Hereditary Angioedema Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Hereditary Angioedema Drug Sales in Volume by Application (2016-2026)
6.2 Global Hereditary Angioedema Drug Revenue by Application (2016-2026)
6.3 Global Hereditary Angioedema Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Hereditary Angioedema Drug Sales by Type (2016-2026)
7.2 North America Hereditary Angioedema Drug Sales by Application (2016-2026)
7.3 North America Hereditary Angioedema Drug Market Size by Country
7.3.1 North America Hereditary Angioedema Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Hereditary Angioedema Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Hereditary Angioedema Drug Sales by Type (2016-2026)
8.2 Europe Hereditary Angioedema Drug Sales by Application (2016-2026)
8.3 Europe Hereditary Angioedema Drug Market Size by Country
8.3.1 Europe Hereditary Angioedema Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Hereditary Angioedema Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Hereditary Angioedema Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Hereditary Angioedema Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Hereditary Angioedema Drug Market Size by Region
9.3.1 Asia-Pacific Hereditary Angioedema Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Hereditary Angioedema Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Hereditary Angioedema Drug Sales by Type (2016-2026)
10.2 South America Hereditary Angioedema Drug Sales by Application (2016-2026)
10.3 South America Hereditary Angioedema Drug Market Size by Country
10.3.1 South America Hereditary Angioedema Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Hereditary Angioedema Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hereditary Angioedema Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Hereditary Angioedema Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Hereditary Angioedema Drug Market Size by Country
11.3.1 Middle East & Africa Hereditary Angioedema Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Hereditary Angioedema Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Hereditary Angioedema Drug Typical Distributors
12.3 Hereditary Angioedema Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Hereditary Angioedema Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Hereditary Angioedema Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Pharming Group NV Basic Information, Manufacturing Base and Competitors
Table 4. Pharming Group NV Major Business
Table 5. Pharming Group NV Hereditary Angioedema Drug Product and Services
Table 6. Pharming Group NV Hereditary Angioedema Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Takeda Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Major Business
Table 9. Takeda Hereditary Angioedema Drug Product and Services
Table 10. Takeda Hereditary Angioedema Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 12. CSL Limited Major Business
Table 13. CSL Limited Hereditary Angioedema Drug Product and Services
Table 14. CSL Limited Hereditary Angioedema Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. IBio Inc. Basic Information, Manufacturing Base and Competitors
Table 16. IBio Inc. Major Business
Table 17. IBio Inc. Hereditary Angioedema Drug Product and Services
Table 18. IBio Inc. Hereditary Angioedema Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. BioCryst Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. BioCryst Pharmaceuticals, Inc. Major Business
Table 21. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product and Services
Table 22. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Ionis Pharmaceuticals, Inc. Major Business
Table 25. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product and Services
Table 26. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Hereditary Angioedema Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 28. Global Hereditary Angioedema Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Hereditary Angioedema Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Hereditary Angioedema Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Hereditary Angioedema Drug Production Site of Key Manufacturer
Table 32. Global Hereditary Angioedema Drug Sales by Region (2016-2021e) & (K Units)
Table 33. Global Hereditary Angioedema Drug Sales by Region (2021-2026) & (K Units)
Table 34. Global Hereditary Angioedema Drug Revenue by Region (2016-2021e) & (USD Million)
Table 35. Global Hereditary Angioedema Drug Revenue by Region (2021-2026) & (USD Million)
Table 36. Global Hereditary Angioedema Drug Sales by Type (2016-2021e) & (K Units)
Table 37. Global Hereditary Angioedema Drug Sales by Type (2021-2026) & (K Units)
Table 38. Global Hereditary Angioedema Drug Revenue by Type (2016-2021e) & (USD Million)
Table 39. Global Hereditary Angioedema Drug Revenue by Type (2021-2026) & (USD Million)
Table 40. Global Hereditary Angioedema Drug Price by Type (2016-2021e) & (USD/Unit)
Table 41. Global Hereditary Angioedema Drug Price by Type (2021-2026) & (USD/Unit)
Table 42. Global Hereditary Angioedema Drug Sales by Application (2016-2021e) & (K Units)
Table 43. Global Hereditary Angioedema Drug Sales by Application (2021-2026) & (K Units)
Table 44. Global Hereditary Angioedema Drug Revenue by Application (2016-2021e) & (USD Million)
Table 45. Global Hereditary Angioedema Drug Revenue by Application (2021-2026) & (USD Million)
Table 46. Global Hereditary Angioedema Drug Price by Application (2016-2021e) & (USD/Unit)
Table 47. Global Hereditary Angioedema Drug Price by Application (2021-2026) & (USD/Unit)
Table 48. North America Hereditary Angioedema Drug Sales by Country (2016-2021e) & (K Units)
Table 49. North America Hereditary Angioedema Drug Sales by Country (2021-2026) & (K Units)
Table 50. North America Hereditary Angioedema Drug Revenue by Country (2016-2021e) & (USD Million)
Table 51. North America Hereditary Angioedema Drug Revenue by Country (2021-2026) & (USD Million)
Table 52. North America Hereditary Angioedema Drug Sales by Type (2016-2021e) & (K Units)
Table 53. North America Hereditary Angioedema Drug Sales by Type (2021-2026) & (K Units)
Table 54. North America Hereditary Angioedema Drug Sales by Application (2016-2021e) & (K Units)
Table 55. North America Hereditary Angioedema Drug Sales by Application (2021-2026) & (K Units)
Table 56. Europe Hereditary Angioedema Drug Sales by Country (2016-2021e) & (K Units)
Table 57. Europe Hereditary Angioedema Drug Sales by Country (2021-2026) & (K Units)
Table 58. Europe Hereditary Angioedema Drug Revenue by Country (2016-2021e) & (USD Million)
Table 59. Europe Hereditary Angioedema Drug Revenue by Country (2021-2026) & (USD Million)
Table 60. Europe Hereditary Angioedema Drug Sales by Type (2016-2021e) & (K Units)
Table 61. Europe Hereditary Angioedema Drug Sales by Type (2021-2026) & (K Units)
Table 62. Europe Hereditary Angioedema Drug Sales by Application (2016-2021e) & (K Units)
Table 63. Europe Hereditary Angioedema Drug Sales by Application (2021-2026) & (K Units)
Table 64. Asia-Pacific Hereditary Angioedema Drug Sales by Region (2016-2021e) & (K Units)
Table 65. Asia-Pacific Hereditary Angioedema Drug Sales by Region (2021-2026) & (K Units)
Table 66. Asia-Pacific Hereditary Angioedema Drug Revenue by Region (2016-2021e) & (USD Million)
Table 67. Asia-Pacific Hereditary Angioedema Drug Revenue by Region (2021-2026) & (USD Million)
Table 68. Asia-Pacific Hereditary Angioedema Drug Sales by Type (2016-2021e) & (K Units)
Table 69. Asia-Pacific Hereditary Angioedema Drug Sales by Type (2021-2026) & (K Units)
Table 70. Asia-Pacific Hereditary Angioedema Drug Sales by Application (2016-2021e) & (K Units)
Table 71. Asia-Pacific Hereditary Angioedema Drug Sales by Application (2021-2026) & (K Units)
Table 72. South America Hereditary Angioedema Drug Sales by Country (2016-2021e) & (K Units)
Table 73. South America Hereditary Angioedema Drug Sales by Country (2021-2026) & (K Units)
Table 74. South America Hereditary Angioedema Drug Revenue by Country (2016-2021e) & (USD Million)
Table 75. South America Hereditary Angioedema Drug Revenue by Country (2021-2026) & (USD Million)
Table 76. South America Hereditary Angioedema Drug Sales by Type (2016-2021e) & (K Units)
Table 77. South America Hereditary Angioedema Drug Sales by Type (2021-2026) & (K Units)
Table 78. South America Hereditary Angioedema Drug Sales by Application (2016-2021e) & (K Units)
Table 79. South America Hereditary Angioedema Drug Sales by Application (2021-2026) & (K Units)
Table 80. Middle East & Africa Hereditary Angioedema Drug Sales by Country (2016-2021e) & (K Units)
Table 81. Middle East & Africa Hereditary Angioedema Drug Sales by Country (2021-2026) & (K Units)
Table 82. Middle East & Africa Hereditary Angioedema Drug Revenue by Country (2016-2021e) & (USD Million)
Table 83. Middle East & Africa Hereditary Angioedema Drug Revenue by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Hereditary Angioedema Drug Sales by Type (2016-2021e) & (K Units)
Table 85. Middle East & Africa Hereditary Angioedema Drug Sales by Type (2021-2026) & (K Units)
Table 86. Middle East & Africa Hereditary Angioedema Drug Sales by Application (2016-2021e) & (K Units)
Table 87. Middle East & Africa Hereditary Angioedema Drug Sales by Application (2021-2026) & (K Units)
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Hereditary Angioedema Drug Typical Distributors
Table 91. Hereditary Angioedema Drug Typical Customers
List of Figures
Figure 1. Hereditary Angioedema Drug Picture
Figure 2. Global Hereditary Angioedema Drug Sales Market Share by Type in 2020
Figure 3. C1 Esterase Inhibitor
Figure 4. Kallikrein Inhibitor
Figure 5. Selective Bradykinin B2 Receptor Antagonist
Figure 6. Global Hereditary Angioedema Drug Sales Market Share by Application in 2020
Figure 7. Retail Pharmacies
Figure 8. Hospital Pharmacies
Figure 9. Online Pharmacies
Figure 10. Global Hereditary Angioedema Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Hereditary Angioedema Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Hereditary Angioedema Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Hereditary Angioedema Drug Sales (2016-2026) & (K Units)
Figure 32. Global Hereditary Angioedema Drug Production Capacity (2016-2026) & (K Units)
Figure 33. Global Hereditary Angioedema Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Hereditary Angioedema Drug Market Drivers
Figure 35. Hereditary Angioedema Drug Market Restraints
Figure 36. Hereditary Angioedema Drug Market Trends
Figure 37. Global Hereditary Angioedema Drug Sales Market Share by Manufacturer in 2020
Figure 38. Global Hereditary Angioedema Drug Revenue Market Share by Manufacturer in 2020
Figure 39. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Hereditary Angioedema Drug Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Hereditary Angioedema Drug Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Hereditary Angioedema Drug Sales Market Share by Region (2016-2026)
Figure 43. Global Hereditary Angioedema Drug Revenue Market Share by Region (2016-2026)
Figure 44. North America Hereditary Angioedema Drug Revenue (2016-2026) & (USD Million)
Figure 45. Europe Hereditary Angioedema Drug Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Hereditary Angioedema Drug Revenue (2016-2026) & (USD Million)
Figure 47. South America Hereditary Angioedema Drug Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Hereditary Angioedema Drug Revenue (2016-2026) & (USD Million)
Figure 49. Global Hereditary Angioedema Drug Sales Market Share by Type (2016-2026)
Figure 50. Global Hereditary Angioedema Drug Revenue Market Share by Type (2016-2026)
Figure 51. Global Hereditary Angioedema Drug Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Hereditary Angioedema Drug Sales Market Share by Application (2016-2026)
Figure 53. Global Hereditary Angioedema Drug Revenue Market Share by Application (2016-2026)
Figure 54. Global Hereditary Angioedema Drug Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Hereditary Angioedema Drug Sales Market Share by Country (2016-2026)
Figure 56. North America Hereditary Angioedema Drug Revenue Market Share by Country (2016-2026)
Figure 57. North America Hereditary Angioedema Drug Sales Market Share by Type (2016-2026)
Figure 58. North America Hereditary Angioedema Drug Sales Market Share by Application (2016-2026)
Figure 59. Europe Hereditary Angioedema Drug Sales Market Share by Country (2016-2026)
Figure 60. Europe Hereditary Angioedema Drug Revenue Market Share by Country (2016-2026)
Figure 61. Europe Hereditary Angioedema Drug Sales Market Share by Type (2016-2026)
Figure 62. Europe Hereditary Angioedema Drug Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Hereditary Angioedema Drug Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Hereditary Angioedema Drug Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Hereditary Angioedema Drug Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Hereditary Angioedema Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Hereditary Angioedema Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Hereditary Angioedema Drug Revenue Market Share by Country (2016-2026)
Figure 69. South America Hereditary Angioedema Drug Sales Market Share by Type (2016-2026)
Figure 70. South America Hereditary Angioedema Drug Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Hereditary Angioedema Drug Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Hereditary Angioedema Drug Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Hereditary Angioedema Drug Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Hereditary Angioedema Drug Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source

以下、関連資料のご紹介

世界の遺伝性血管浮腫治療市場 2021：企業別、地域別、種類・用途別

Global Hereditary Angioedema Treatment Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z06896 2021年4月 105Pages
当調査資料では、遺伝性血管浮腫治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝性血管浮腫治療の種類別市場規模（C1エステラーゼ阻害剤（血漿製品、組換え製品）、選択的ブラジキニンB2受容体拮抗薬、カリクレイン阻害剤、その他（従来薬、パイプライン薬...

世界の遺伝性がん検査市場規模・現状・予測（2021年-2027年）

Global Hereditary Cancer Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2806 2021年4月 125Pages
QYResearch社発行の本調査資料では、遺伝性がん検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RNA検査、DNA検査）、用途別市場規模（乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他のがん）、主要地域別市場規模（北米、アメリ...

世界のタミフル（オセルタミビル）薬市場 2021：企業別、地域別、種類・用途別

Global Tamiflu (Oseltamivir) Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z13609 2021年4月 108Pages
当調査資料では、タミフル（オセルタミビル）薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。タミフル（オセルタミビル）薬の種類別市場規模（カプセル、経口液剤）、用途別市場規模（インフルエンザA、インフルエンザB）、地域別市場規模（北米、アメリカ、ヨーロ...

世界のフルバスタチンナトリウム薬市場 2021：企業別、地域別、種類・用途別

Global Fluvastatin Sodium Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z05938 2021年4月 100Pages
当調査資料では、フルバスタチンナトリウム薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。フルバスタチンナトリウム薬の種類別市場規模（錠剤、カプセル）、用途別市場規模（大人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南ア...

世界の深部静脈血栓症（DVT）治療薬市場 2021：企業別、地域別、種類・用途別

Global Deep Vein Thrombosis (DVT) Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z04188 2021年4月 106Pages
当調査資料では、深部静脈血栓症（DVT）治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。深部静脈血栓症（DVT）治療薬の種類別市場規模（抗凝血剤、組織プラスミノーゲン活性化因子、その他薬）、用途別市場規模（病院、診療所、ドラッグストア）、地域別市...

世界の喘息＆COPD薬市場 2021：企業別、地域別、種類・用途別

Global Asthma and COPD Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z01168 2021年4月 102Pages
当調査資料では、喘息＆COPD薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。喘息＆COPD薬の種類別市場規模（気管支拡張薬、抗炎症薬、モノクローナル抗体、併用薬）、用途別市場規模（喘息、COPD）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界のソタロール薬市場 2021：企業別、地域別、種類・用途別

Global Sotalol Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z12976 2021年4月 104Pages
当調査資料では、ソタロール薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ソタロール薬の種類別市場規模（錠剤、経口液剤、注射剤）、用途別市場規模（心室性不整脈、上室性不整脈）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア...

世界のトリプトレリン薬市場 2021：企業別、地域別、種類・用途別

Global Triptorelin Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z14185 2021年4月 101Pages
当調査資料では、トリプトレリン薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。トリプトレリン薬の種類別市場規模（3.75 mgバイアル、11.25 mgバイアル、22.5mgバイアル）、用途別市場規模（進行性前立腺がん、子宮内膜症、子宮筋腫）、地域別...

世界のミルタザピン薬市場 2021：企業別、地域別、種類・用途別

Global Mirtazapine Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z09445 2021年4月 108Pages
当調査資料では、ミルタザピン薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ミルタザピン薬の種類別市場規模（15mg錠、30mg錠、45mg錠）、用途別市場規模（病院、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、...

世界のビバリルジン薬市場 2021：企業別、地域別、種類・用途別

Global Bivalirudin Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z02273 2021年4月 106Pages
当調査資料では、ビバリルジン薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ビバリルジン薬の種類別市場規模（注射、粉末）、用途別市場規模（病院、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、...

世界の遺伝性血管浮腫治療市場 2021：企業別、地域別、種類・用途別 The Hereditary Angioedema Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
世界の遺伝性がん検査市場規模・現状・予測（2021年-2027年） Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation fr…
世界の血漿プロテアーゼC1阻害剤治療市場規模・現状・予測（2021年-2027年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…
世界の小売薬市場規模・現状・予測（2021年-2027年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
世界の喉頭蓋炎治療薬市場規模・現状・予測（2021年-2027年） Epiglottitis is a bacterial viral infection which results in inflammation and swelling of epiglottis, basically epiglottis is a cartilage structure which located at the back of the throat, beneath the tongue and the function of epiglottis is close over the trachea when foods are being swallowed, Epi…